Author:
Rindi Guido,Wiedenmann Bertram
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference106 articles.
1. Yao, J. C. et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 26, 3063–3072 (2008).
2. Modlin, I. M., Moss, S. F., Chung, D. C., Jensen, R. T. & Snyderwine, E. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J. Natl Cancer Inst. 100, 1282–1289 (2008).
3. Bosman, F. T., Carneiro, F., Hruban, R. H. & Theise, N. D. (Eds) WHO Classification of Tumours of the Digestive System 4th edn Vol. 3 (IARC Press, Lyon, 2010).
4. Yao, J. C. et al. Everolimus for advanced pancreatic neuroendocrine tumors. N. Engl. J. Med. 364, 514–523 (2011).
5. Raymond, E., Faivre, S., Hammel, P. & Ruszniewski, P. Sunitinib paves the way for targeted therapies in neuroendocrine tumors. Target. Oncol. 4, 253–254 (2009).
Cited by
172 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献